Seeking Alpha
Deep value, long/short equity, event-driven, research analyst
Profile| Send Message|
( followers)  

Challenging the consensus is quite difficult and requires guts of steel. Contrarians have to shut out the allure of stories, interviews in the financial media, and other distractions in order to focus on valuation. Today, independent thinkers are also confronted with the challenge of identifying the consensus. Who isn't a contrarian or a value investor today? How can a consensus be identified when everyone claims to be different?

Even though Jim Cramer's trades are not long-term recommendations, his picks can be a very useful barometer of investor and media attitudes. Contrarians can use his picks as an indicator of current market sentiment to selectively counter.

Cramer recently issued 89 buy and sell stock opinions on his Mad Money program (7.16.2012 to 7.19.2012). Of these calls, three sell calls and three buy calls can be challenged on a valuation basis. Infosys (NYSE:INFY), Alaska Air Group (NYSE:ALK), and AGCO Corporation (NYSE:AGCO) are too cheaply valued to be Sell picks. On the other hand, Edwards Lifesciences (NYSE:EW), Verizon Communications (NYSE:VZ), Dunkin' Brands Group (NASDAQ:DNKN) are too richly valued to be Buy picks.

These picks are summarized below:

Ticker

Cramer's Call

Airdate

P/E

P/B

P/S

Insider Transactions

INFY

Sell

7.18.2012

12.92

3.73

3.19

0.0%

ALK

Sell

7.17.2012

12.39

2.09

0.58

32.6%

EW

Buy

7.17.2012

50.54

8.29

6.68

-4.9%

VZ

Buy

7.17.2012

47.84

3.45

1.13

-27.5%

DNKN

Buy

7.17.2012

65.12

5.34

6.24

-98.7%

AGCO

Sell

7.16.2012

6.68

1.28

0.45

1.2%

After reviewing the price multiples of EW, VZ, and DNKN, it is clear that these stocks are richly-valued according to static valuation metrics. The only metric that is attracted for any of these stocks is the price-to-sales ratio of VZ. In addition, net insider selling of these picks over the past six months is also discouraging.

Sadly, even pleasant future growth scenarios are not much consolation for such richly valued stocks. What could an investor expect from these picks?

Total returns were calculated over a three year holding period for these stocks. (I use a 3-year holding period, since above-average growth estimates are not reliable further out.) Giving these Buy recommendations the benefit of the doubt, each stock is assumed to be sold at a generous growth stock price-to-earnings multiple of 17, and the maximum of historical and analyst estimate values for earnings growth are assumed. These assumptions are used to project an annualized total return over the next three years and terminal price to earnings ratios, that is,the price paid today divided by earnings at the end of the holding period for each stock:

3 Years Growth

Ticker

Cramer's Call

g (past)

g (future)

Terminal P/E

Annualized Return

EW

Buy

13.5%

26.9%

24.7

-11.7%

VZ

Buy

-14.7%

9.2%

36.7

-21.5%

DNKN

Buy

0.0%

16.1%

41.6

-25.4%

Even after incorporating optimistic earnings growth, these stocks are just too expensive.

Alternatively, INFY, ALK, and AGCO were discovered as contrarian Buy picks with attractive valuations by sifting through the week's Sell recommendations. These contrarian Buy candidates were evaluated using conservative assumptions. A bargain value stock price to earnings multiple of 10 and the lesser of historical and analyst estimates values for earnings growth are assumed. These assumptions are used to project an annualized total return over the next three years, and a terminal price to earnings ratio, that is, price paid today divided by earnings at the end of the holding period for each stock:

3 Years Growth

Ticker

Cramer's Call

g (past)

g (future)

Terminal P/E

Annualized Return

INFY

Sell

14.9%

14.4%

8.6

5.6%

ALK

Sell

8.0%

26.0%

9.8

0.5%

AGCO

Sell

11.1%

15.1%

4.9

27.1%

The attractive valuations of these stocks protect investors from tough scenarios, providing them with better odds for positive returns.

These projected returns ignore stories and current sentiment while using valuation and math to demonstrate how buying expensive stocks can cost investors dearly. They flip the script on these six stock calls.

Read the article disclaimer.

Source: Valuation-Based Contrarian Picks